Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How can I manage the financial risks arising from exchange rate fluctuations if my business involves importing medicines from overseas?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q274 · Category F: Fees, budgeting and financial planning (Q251–Q300)
For wholesalers needing to import medicines from overseas (such as Europe, the US or Japan), managing foreign exchange risk is an important part of financial planning. Sharp exchange-rate fluctuations can directly affect procurement costs and profit margins. Effective strategies include: 1. “Use forward foreign exchange contracts”: enter into a contract with a bank to lock in the exchange rate for purchasing foreign currency at a future date, thereby fixing costs. 2. “Open multi-currency accounts”: hold a certain amount of commonly used foreign currencies (such as US dollars or euros), buying them when exchange rates are favourable for future payments. 3. “Negotiate pricing terms with suppliers”: try to include a clause in the purchase contract allocating the impact of exchange-rate fluctuations, or seek to agree prices in a relatively stable currency such as Hong Kong dollars or US dollars.

📘 Regulatory basis

Although no regulations directly require foreign exchange hedging, the Pharmaceutical Wholesaler Licensing Guide requires licence holders to have a sound financial position to maintain their business. An inability to manage exchange rate risk effectively may be regarded as evidence of financial instability.

📗 Drew Tang's recommendations

For start-ups, we do not recommend complex foreign exchange derivatives transactions. The simplest and most effective approach is to build an exchange-rate risk buffer (for example, 5%) into your pricing model to absorb a degree of adverse exchange-rate movement. Maintaining a higher gross margin is also fundamental to mitigating various risks.

📕 Risk notice

Ignoring foreign exchange risk entirely may result in a major adverse exchange rate movement wiping out the profit on an entire shipment or even causing a loss. If your selling price is based entirely on the current spot rate and you ignore the time between placing an order and making payment, you may be exposing yourself to financial risk.

Back to Category F: Fees, Budget and Financial Planning (Q251-Q300) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗